• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cancer Diagnoses After Recent Weight Loss.近期体重减轻后的癌症诊断。
JAMA. 2024 Jan 23;331(4):318-328. doi: 10.1001/jama.2023.25869.
2
Racial and Ethnic Disparities in All-Cause and Cause-Specific Mortality Among US Youth.美国青年全因死亡率和死因特异性死亡率的种族和民族差异。
JAMA. 2024 May 28;331(20):1732-1740. doi: 10.1001/jama.2024.3908.
3
Identifying and Mitigating Disparities in Central Line-Associated Bloodstream Infections in Minoritized Racial, Ethnic, and Language Groups.识别和减轻少数种族、族裔和语言群体中心静脉相关血流感染的差异。
JAMA Pediatr. 2023 Jul 1;177(7):700-709. doi: 10.1001/jamapediatrics.2023.1379.
4
Survival Outcomes by Race and Ethnicity in Veterans With Nonmetastatic Castration-Resistant Prostate Cancer.非转移性去势抵抗性前列腺癌退伍军人的种族和民族的生存结果。
JAMA Netw Open. 2023 Oct 2;6(10):e2337272. doi: 10.1001/jamanetworkopen.2023.37272.
5
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial.阿司匹林与安慰剂作为乳腺癌辅助治疗的比较:ALLIANCE A011502 随机试验。
JAMA. 2024 May 28;331(20):1714-1721. doi: 10.1001/jama.2024.4840.
6
Diabetes, Weight Change, and Pancreatic Cancer Risk.糖尿病、体重变化与胰腺癌风险。
JAMA Oncol. 2020 Oct 1;6(10):e202948. doi: 10.1001/jamaoncol.2020.2948. Epub 2020 Oct 8.
7
Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening.种族和民族调整后开始乳腺癌筛查的年龄建议。
JAMA Netw Open. 2023 Apr 3;6(4):e238893. doi: 10.1001/jamanetworkopen.2023.8893.
8
State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer Among US Women.美国女性中三阴性乳腺癌发病率的种族和民族差异的州际变化。
JAMA Oncol. 2023 May 1;9(5):700-704. doi: 10.1001/jamaoncol.2022.7835.
9
Race and Ethnicity and Prehospital Use of Opioid or Ketamine Analgesia in Acute Traumatic Injury.种族和民族与急性创伤性损伤院前使用阿片类或氯胺酮镇痛剂。
JAMA Netw Open. 2023 Oct 2;6(10):e2338070. doi: 10.1001/jamanetworkopen.2023.38070.
10
Race and Ethnicity Representation in Phase 2/3 Oncology Clinical Trial Publications: A Systematic Review.种族和民族在 2/3 期肿瘤临床试验出版物中的代表性:一项系统评价。
JAMA Health Forum. 2024 Jun 7;5(6):e241388. doi: 10.1001/jamahealthforum.2024.1388.

引用本文的文献

1
Risk of atherosclerotic cardiovascular disease after cancer diagnosis: findings from three prospective cohort studies.癌症诊断后发生动脉粥样硬化性心血管疾病的风险:三项前瞻性队列研究的结果
J Natl Cancer Inst. 2025 May 30. doi: 10.1093/jnci/djaf122.
2
To what extent is the association between obesity and colorectal cancer risk mediated by systemic inflammation?肥胖与结直肠癌风险之间的关联在多大程度上是由全身炎症介导的?
Cancer Commun (Lond). 2025 Apr;45(4):456-459. doi: 10.1002/cac2.12659. Epub 2025 Jan 10.
3
Mortality, Hepatic Decompensation, and Cardiovascular Outcomes in Lean vs. Non-lean MASLD Cirrhosis: A Veterans Affairs Cohort Study.瘦型与非瘦型非酒精性脂肪性肝病肝硬化患者的死亡率、肝失代偿及心血管结局:一项退伍军人事务部队列研究
Dig Dis Sci. 2025 Feb;70(2):802-813. doi: 10.1007/s10620-024-08764-4. Epub 2025 Jan 8.
4
Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies.胰腺癌的早期检测:生物标志物发现及早期验证研究中的研究设计与分析考量
Pancreatology. 2024 Dec;24(8):1265-1279. doi: 10.1016/j.pan.2024.10.012. Epub 2024 Oct 29.
5
Reevaluating the fraction of cancer attributable to excess weight: overcoming the hidden impact of prediagnostic weight loss.重新评估超重导致的癌症比例:克服诊断前体重减轻的隐藏影响。
Eur J Epidemiol. 2024 Sep;39(9):991-1003. doi: 10.1007/s10654-024-01146-0. Epub 2024 Sep 18.
6
Association of midlife body-weight variability and cycles with earlier dementia onset: a nationwide cohort study.中年体重波动和周期与更早痴呆发病的关联:一项全国性队列研究。
Alzheimers Res Ther. 2024 Apr 25;16(1):91. doi: 10.1186/s13195-024-01460-5.

本文引用的文献

1
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
2
Measured weight loss as a precursor to cancer diagnosis: retrospective cohort analysis of 43 302 primary care patients.测量体重减轻作为癌症诊断的前兆:对 43302 名初级保健患者的回顾性队列分析。
J Cachexia Sarcopenia Muscle. 2022 Oct;13(5):2492-2503. doi: 10.1002/jcsm.13051. Epub 2022 Jul 28.
3
Validity and Relative Validity of Alternative Methods of Assessing Physical Activity in Epidemiologic Studies: Findings From the Men's Lifestyle Validation Study.在流行病学研究中评估身体活动的替代方法的有效性和相对有效性:来自男性生活方式验证研究的结果。
Am J Epidemiol. 2022 Jun 27;191(7):1307-1322. doi: 10.1093/aje/kwac051.
4
Reproducibility and validity of diet quality scores derived from food-frequency questionnaires.基于食物频率问卷的膳食质量评分的可重复性和有效性。
Am J Clin Nutr. 2022 Mar 4;115(3):843-853. doi: 10.1093/ajcn/nqab368.
5
Combining simple blood tests to identify primary care patients with unexpected weight loss for cancer investigation: Clinical risk score development, internal validation, and net benefit analysis.结合简单的血液检查,识别接受初级保健的有意外体重减轻表现的患者以进行癌症检查:临床风险评分的制定、内部验证和净收益分析。
PLoS Med. 2021 Aug 31;18(8):e1003728. doi: 10.1371/journal.pmed.1003728. eCollection 2021 Aug.
6
Weight Loss as an Untapped Early Detection Marker in Pancreatic and Periampullary Cancer.体重减轻作为胰腺和壶腹周围癌的未开发早期检测标志物。
Ann Surg Oncol. 2021 Oct;28(11):6283-6292. doi: 10.1245/s10434-021-09861-8. Epub 2021 Apr 9.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
Diabetes, Weight Change, and Pancreatic Cancer Risk.糖尿病、体重变化与胰腺癌风险。
JAMA Oncol. 2020 Oct 1;6(10):e202948. doi: 10.1001/jamaoncol.2020.2948. Epub 2020 Oct 8.
9
The association between unexpected weight loss and cancer diagnosis in primary care: a matched cohort analysis of 65,000 presentations.在初级保健中,意外体重减轻与癌症诊断之间的关联:对 65000 例就诊病例的匹配队列分析。
Br J Cancer. 2020 Jun;122(12):1848-1856. doi: 10.1038/s41416-020-0829-3. Epub 2020 Apr 15.
10
Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study.诊断时癌症的表现症状和分期:一项基于人群的横断面研究证据。
Lancet Oncol. 2020 Jan;21(1):73-79. doi: 10.1016/S1470-2045(19)30595-9. Epub 2019 Nov 6.

近期体重减轻后的癌症诊断。

Cancer Diagnoses After Recent Weight Loss.

机构信息

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard University, Boston, Massachusetts.

Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden.

出版信息

JAMA. 2024 Jan 23;331(4):318-328. doi: 10.1001/jama.2023.25869.

DOI:10.1001/jama.2023.25869
PMID:38261044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10807298/
Abstract

IMPORTANCE

Weight loss is common in primary care. Among individuals with recent weight loss, the rates of cancer during the subsequent 12 months are unclear compared with those without recent weight loss.

OBJECTIVE

To determine the rates of subsequent cancer diagnoses over 12 months among health professionals with weight loss during the prior 2 years compared with those without recent weight loss.

DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort analysis of females aged 40 years or older from the Nurses' Health Study who were followed up from June 1978 until June 30, 2016, and males aged 40 years or older from the Health Professionals Follow-Up Study who were followed up from January 1988 until January 31, 2016.

EXPOSURE

Recent weight change was calculated from the participant weights that were reported biennially. The intentionality of weight loss was categorized as high if both physical activity and diet quality increased, medium if only 1 increased, and low if neither increased.

MAIN OUTCOME AND MEASURES

Rates of cancer diagnosis during the 12 months after weight loss.

RESULTS

Among 157 474 participants (median age, 62 years [IQR, 54-70 years]; 111 912 were female [71.1%]; there were 2631 participants [1.7%] who self-identified as Asian, Native American, or Native Hawaiian; 2678 Black participants [1.7%]; and 149 903 White participants [95.2%]) and during 1.64 million person-years of follow-up, 15 809 incident cancer cases were identified (incident rate, 964 cases/100 000 person-years). During the 12 months after reported weight change, there were 1362 cancer cases/100 000 person-years among all participants with recent weight loss of greater than 10.0% of body weight compared with 869 cancer cases/100 000 person-years among those without recent weight loss (between-group difference, 493 cases/100 000 person-years [95% CI, 391-594 cases/100 000 person-years]; P < .001). Among participants categorized with low intentionality for weight loss, there were 2687 cancer cases/100 000 person-years for those with weight loss of greater than 10.0% of body weight compared with 1220 cancer cases/100 000 person-years for those without recent weight loss (between-group difference, 1467 cases/100 000 person-years [95% CI, 799-2135 cases/100 000 person-years]; P < .001). Cancer of the upper gastrointestinal tract (cancer of the esophagus, stomach, liver, biliary tract, or pancreas) was particularly common among participants with recent weight loss; there were 173 cancer cases/100 000 person-years for those with weight loss of greater than 10.0% of body weight compared with 36 cancer cases/100 000 person-years for those without recent weight loss (between-group difference, 137 cases/100 000 person-years [95% CI, 101-172 cases/100 000 person-years]; P < .001).

CONCLUSIONS AND RELEVANCE

Health professionals with weight loss within the prior 2 years had a significantly higher risk of cancer during the subsequent 12 months compared with those without recent weight loss. Cancer of the upper gastrointestinal tract was particularly common among participants with recent weight loss compared with those without recent weight loss.

摘要

重要性:体重减轻在初级保健中很常见。在最近体重减轻的人群中,与最近没有体重减轻的人群相比,在随后的 12 个月内癌症的发生率尚不清楚。

目的:确定与最近没有体重减轻的人群相比,在过去 2 年内体重减轻的健康专业人员在随后的 12 个月内诊断出癌症的发生率。

设计、地点和参与者:前瞻性队列分析,纳入年龄在 40 岁及以上的女性,来自护士健康研究,随访时间从 1978 年 6 月至 2016 年 6 月 30 日;纳入年龄在 40 岁及以上的男性,来自健康专业人员随访研究,随访时间从 1988 年 1 月至 2016 年 1 月 31 日。

暴露:参与者的体重变化是根据每两年报告的体重计算得出的。体重减轻的意图被归类为高,如果体力活动和饮食质量都增加;中,如果只有 1 项增加;低,如果都没有增加。

主要结果和措施:体重减轻后 12 个月内癌症的诊断率。

结果:在 157474 名参与者(中位年龄,62 岁[IQR,54-70 岁];111912 名女性[71.1%];2631 名参与者[1.7%]自我认定为亚裔、美洲原住民或夏威夷原住民;2678 名黑人参与者[1.7%];149903 名白人参与者[95.2%])和 1640 万人年的随访中,共发现 15809 例新发癌症病例(发病率为 964 例/10 万人年)。在报告体重变化后的 12 个月内,与最近没有体重减轻的人群相比,体重减轻超过 10.0%的所有参与者中有 1362 例癌症病例/10 万人年(组间差异,493 例/10 万人年[95%CI,391-594 例/10 万人年];P<0.001)。在体重减轻意图归类为低的参与者中,体重减轻超过 10.0%的人群中有 2687 例癌症病例/10 万人年,而最近没有体重减轻的人群中有 1220 例癌症病例/10 万人年(组间差异,1467 例/10 万人年[95%CI,799-2135 例/10 万人年];P<0.001)。上消化道癌症(食管、胃、肝、胆道或胰腺癌症)在最近体重减轻的参与者中尤为常见;与最近没有体重减轻的人群相比,体重减轻超过 10.0%的人群中有 173 例癌症病例/10 万人年(组间差异,137 例/10 万人年[95%CI,101-172 例/10 万人年];P<0.001)。

结论:与最近没有体重减轻的人群相比,在过去 2 年内体重减轻的健康专业人员在随后的 12 个月内癌症风险显著增加。与最近没有体重减轻的人群相比,上消化道癌症在最近体重减轻的参与者中尤为常见。